Sympathetic stimulation for improved myocardial relaxation

• US 8,498,704 B2
• Filed: 02/02/2011
• Issued: 07/30/2013
• Est. Priority Date: 02/03/2010
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Shuros, Allan C., Arcot-Krishnamurthy, Shantha, Alvarez, Guy
• Primary Examiner(s): Koharski, Chrhistopher D
• Assistant Examiner(s): VOORHEES, CATHERINE M
• Application Number:
  US13/019,818
• Publication Number:
  US 20110190840A1
• Time in Patent Office: 909 Days
• Field of Search: 607 2- 5, 607 17- 19, 607/23, 607/25
• US Class Current: 607/19
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/36564 controlled by blood pressure

Abstract

Described are methods and devices for improving diastolic function with electrostimulation in heart failure patients who exhibit relatively normal systolic function. Such patients are characterized by impaired myocardial relaxation during diastole that prevents adequate filling of the ventricles during diastole to thereby reduce cardiac output. An implantable device is described for effecting strategic and periodic stimulation of the sympathetic nervous system to elicit myocardial adrenergic activation for improved myocardial relaxation.

Claims

1. A device, comprising:

neural stimulation circuitry for delivering electrostimulation pulses to one or more electrodes adapted for stimulating sympathetic nerves innervating the heart of a patient;

lusitropy sensing circuitry for measuring ventricular isovolumic relaxation time; and

,

a controller programmed to compare the measured ventricular isovolumic relaxation time to a specified threshold in order to determine if diastolic relaxation is impaired and, when diastolic relaxation is impaired, enter a neural stimulation mode for operating the neural stimulation circuitry to deliver sympathetic stimulation to the heart.

2. The device of claim 1 further comprising cardiac sensing circuitry for connecting to one or more electrodes to sense cardiac electrical activity and wherein the controller is connected to the cardiac sensing circuitry and programmed to deliver sympathetic stimulation to the heart by operating the neural stimulation circuitry to deliver electrostimulation pulses during a cardiac refractory period occurring at specified time interval after a detected cardiac depolarization.

3. The device of claim 2 wherein the controller is programmed to vary the specified time interval for delivering electrostimulation pulses with heart rate.

4. The device of claim 1 further comprising:

an exertion level sensor selected from an accelerometer or a minute ventilation sensor for measuring the patient'"'"'s exertion level;

an atrial stimulation channel and a ventricular stimulation channel both connected to the neural stimulation circuitry, wherein the atrial stimulation channel is configured to stimulate atrial sympathetic nerves and the ventricular stimulation channel is configured to stimulate ventricular sympathetic nerves;

wherein, in the neural stimulation mode, the controller is programmed to deliver electrostimulation pulses through both the atrial and ventricular stimulation channels when the exertion level is above a specified threshold value and deliver electrostimulation pulses through only the ventricular stimulation channel when the exertion level is not above the specified threshold value.

5. The device of claim 4 wherein, in the neural stimulation mode, the controller is configured to deliver electrostimulation pulses through the ventricular stimulation channel on an intermittent basis to exert a conditioning effect when the exertion level is not above the specified threshold value.

6. The device of claim 1 wherein the controller is further programmed to adjust one or more neural stimulation parameters selected from a neural stimulation duty cycle, an electrostimulation pulse amplitude, or an electrode configuration in accordance with the measured ventricular isovolumic relaxation time.

7. The device of claim 1 further comprising an accelerometer adapted for subcutaneous disposition in order to detect skeletal muscle contraction and wherein the controller is programmed to adjust one or more neural stimulation parameters when skeletal muscle contraction is detected.

8. The device of claim 1 further comprising an impedance sensor for measuring ventricular volume and wherein the lusitropy sensing circuitry is configured to measure ventricular isovolumic relaxation time as indicated by the measured ventricular volume.

9. The device of claim 1 further comprising a heart sound sensor and wherein the lusitropy sensing circuitry is configured to measure ventricular isovolumic relaxation time as the interval between aortic valve closure and mitral valve opening as detected by the heart sound sensor.

10. The device of claim 1 further comprising cardiac sensing circuitry for connecting to one or more electrodes to sense cardiac electrical activity and wherein the controller is connected to the cardiac sensing circuitry and programmed to measure heart rate during delivery of sympathetic stimulation and to discontinue the neural stimulation mode if the heart rate increases above a specified safety threshold value.

11. The device of claim 1 further comprising cardiac sensing circuitry for connecting to one or more electrodes to sense cardiac electrical activity and wherein the controller is connected to the cardiac sensing circuitry and programmed to measure heart rate during delivery of sympathetic stimulation and to continue delivery of sympathetic stimulation if no heart rate increase and no change in the ventricular isovolumic relaxation time occurs in response thereto.

12. A method for operating an implantable device in a patient, comprising:

measuring ventricular isovolumic relaxation time; and

,

comparing the measured isovolumic relaxation time to a specified threshold in order to determine if diastolic relaxation is impaired and, when diastolic relaxation is impaired, entering a neural stimulation mode to deliver electrostimulation pulses to one or more electrodes adapted for stimulating sympathetic nerves innervating the heart.

13. The method of claim 12 further comprising delivering sympathetic stimulation to the heart by delivering electrostimulation pulses during a cardiac refractory period occurring at specified time interval after a detected cardiac depolarization.

14. The method of claim 13 further comprising varying the specified time interval for delivering electrostimulation pulses with heart rate.

15. The method of claim 12 further comprising:

measuring the patient'"'"'s exertion level;

delivering electrostimulation pulses either through an atrial stimulation channel configured to stimulate atrial sympathetic nerves or through a ventricular stimulation channel configured to stimulate ventricular sympathetic nerves; and

,

in the neural stimulation mode, delivering electrostimulation pulses through both the atrial and ventricular stimulation channels when the exertion level is above a specified threshold value and delivering electrostimulation pulses through only the ventricular stimulation channel when the exertion level is not above the specified threshold value.

16. The method of claim 15 further comprising, in the neural stimulation mode, delivering electrostimulation pulses through the ventricular stimulation channel on an intermittent basis to exert a conditioning effect when the exertion level is not above the specified threshold value.

17. The method of claim 12 further comprising adjusting one or more neural stimulation parameters selected from a neural stimulation duty cycle, an electrostimulation pulse amplitude, or particular electrodes to which the neural stimulation is delivered in accordance with the measured ventricular isovolumic relaxation time.

18. The method of claim 12 further comprising detecting skeletal muscle contraction and adjusting one or more neural stimulation parameters when skeletal muscle contraction is detected.

19. The method of claim 12 wherein ventricular isovolumic relaxation time is measured by an impedance sensor for measuring ventricular volume.

20. The method of claim 12 wherein ventricular isovolumic relaxation time is measured as the interval between aortic valve closure and mitral valve opening as detected by a heart sound sensor.

21. The method of claim 12 further comprising measuring heart rate during delivery of sympathetic stimulation and discontinuing the neural stimulation mode if the heart rate increases above a specified safety threshold value.